Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-03-07
1991-03-19
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 19, 530331, 540531, 544 582, 544168, 546216, 546243, A61K 3743, C07K 508, C07D27910, C07D26530
Patent
active
050011138
ABSTRACT:
Enzyme di- or tripeptides of the formula: ##STR1## and analogs thereof which inhibit renin and are useful for treating various forms of renin-associated hypertension, hyperaldosteronism and congestive heart failure; compositions containing these renin-inhibitory peptides, optionally with other antihypertensive agents; and methods of treating hypertension, hyperaldosteronism or congestive heart failure or of establishing renin as a causative factor in these problems which employ these novel peptides.
REFERENCES:
patent: 4705846 (1987-11-01), Thaisrivongs
Veber Daniel E.
Williams Peter D.
Caruso Charles M.
Daniel Mark R.
Lee Lester L.
Merck & Co. , Inc.
LandOfFree
Di- or tripeptide renin inhibitors containing lactam conformatio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Di- or tripeptide renin inhibitors containing lactam conformatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Di- or tripeptide renin inhibitors containing lactam conformatio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2010144